The US Food and Drug Administration has not said how long it will take to study the vaccine data, but the government expects to give the green light for the vaccine in the first two weeks of December.
Preliminary projections make the availability of one or several vaccines seem possible by autumn 2020," the Robert Koch Institute said in a statement on its website, citing a global effort to bring immunisations to market.
The total number of doses provided up to Friday stands at 2,339,073 with a rate of vaccine distribution of 23.65 doses per 100 people.
News last week that Moderna’s vaccine has been approved in the UK warrants hope, optimism, and a huge sense of relief – but on the other hand, does it? While the US-developed Covid jab was busy becoming the third to be approved by the Medicines and Healthcare
Despite growing vaccine access, January is looking grim around the globe as the virus resurges and reshapes itself from Britain to Japan to California, filling hospitals and threatening livelihoods anew as governments lock down businesses and race
The total number of doses provided up to Wednesday stands at 3,691,591 with a rate of vaccine distribution of 37.32 doses per 100 people.
The row came as Italy prepared the next stage of its gradual easing of a national lockdown imposed three months ago to fight the spread of the deadly virus.
The scientists at University of Oxford’s Jenner Institute and the Oxford Vaccine Group have expressed concerns that they may not be able to complete their research since the virus is diminishing in the UK. The Oxford scientists group should consider commencing simultaneous trials in Africa, at Kenya and in Asia, say India, where the virus is yet very strong. The trials should go on.
Scientists still predict a safe and effective vaccine against SARS-CoV-2, the virus that causes COVID-19 could take at least 12-18 months to develop, according to a new report from a section of the media.